|Articles|December 1, 2000

PEDIATRIC PUZZLER Delayed growth and sexual development in a 15-year-old:A rose by any other name

The 15 1/2-year-old seated in your office is obviously uncomfortable. He has been referred for evaluation by his physician because of decreased growth and failure to develop secondary sexual characteristics, or, as he puts it, "not developing like the other boys."

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

PEDIATRIC PUZZLER Delayed growth and sexual development in a 15-year-old:A rose by any other name

Related Content

Top 5 pediatric health headlines you missed in May 2026

Supporting children with hidradenitis suppurativa beyond medical treatment, with Colleen Cotton, MD

Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation

FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults

Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation

FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults

Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa

Colleen Cotton, MD, on the importance of early recognition in hidradenitis suppurativa

FDA accepts mavacamten (Camzyos) application for adolescent obstructive hypertrophic cardiomyopathy